Associated Papers
Complex Genetics in Somatic Mosaic Disorders: Evaluating the Rate of Multiple "Hits" in Non-Malignant Lesions.
Nguyen B et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc, 2026
Ultra-deep targeted next-generation sequencing with peripheral blood in patients with vascular malformations: a cohort of 40 patients.
Mitamura S et al.
Molecular Biology Reports, 2025
Blue Nodules in a 2-Year-Old Female With Chronic Severe Anemia.
Ross KR et al.
International Journal of Dermatology, 2025
Theragnostic approach of venous malformations in 2025: Similarities and differences with oncology advances.
Dompmartin A et al.
Presse Medicale (paris, France : 1983), 2025
Comprehensive Analysis of TEK Variants in Patients With Vascular Malformations.
Ghasemi R et al.
Clinical Genetics, 2025
Comprehensive phenotypic and genomic characterization of venous malformations.
Hirose K et al.
Human Pathology, 2024
Co-existence of 2 clinically significant variants causing disorders of somatic mosaicism.
Cao Y et al.
Genetics in Medicine Open, 2023
Comprehensive targeted next-generation sequencing in patients with slow-flow vascular malformations.
Nozawa A et al.
Journal of Human Genetics, 2022
The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms.
Butnariu LI et al.
International Journal of Molecular Sciences, 2022
Clinical and Molecular Spectrum of Sporadic Vascular Malformations: A Single-Center Study.
Diociaiuti A et al.
Biomedicines, 2022
A pediatric case of TEK-Related malformations and marfanoid habitus: an incidental finding or a feature?
Buonuomo PS et al.
Lymphology, 2022
Somatic Variant Analysis Identifies Targets for Tailored Therapies in Patients with Vascular Malformations.
Paolacci S et al.
Journal of Clinical Medicine, 2020
The Pathogenesis of Port Wine Stain and Sturge Weber Syndrome: Complex Interactions between Genetic Alterations and Aberrant MAPK and PI3K Activation.
Nguyen V et al.
International Journal of Molecular Sciences, 2019
Ponatinib Combined With Rapamycin Causes Regression of Murine Venous Malformation.
Li X et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2019
Etiology and Genetics of Congenital Vascular Lesions.
Queisser A et al.
Otolaryngologic Clinics of North America, 2018
Review of the endothelial pathogenic mechanism of TIE2-related venous malformation.
Du Z et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders, 2017
Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations.
Soblet J et al.
The Journal of Investigative Dermatology, 2017
Common and specific effects of TIE2 mutations causing venous malformations.
Nätynki M et al.
Human Molecular Genetics, 2015
Classification and Tie2 mutations in spinal and soft tissue vascular anomalies.
Zhou M et al.
Gene, 2015
Variable Somatic TIE2 Mutations in Half of Sporadic Venous Malformations.
Soblet J et al.
Molecular Syndromology, 2013
KIDs rule: regulatory phosphorylation of RTKs.
Locascio LE et al.
Trends in Biochemical Sciences, 2013
Somatic mutations in exon 17 of the TEK gene in vascular tumors and vascular malformations.
Ye C et al.
Journal of Vascular Surgery, 2011
Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.
Limaye N et al.
Nature Genetics, 2009